Pharmacist, engineer principals in company linked to meningitis outbreak

  • By JAY LINDSAY
    Associated Press
  • Sunday, October 14th, 2012
  • Text size: A A A
Two men stand guard outside the entrance to Ameridose LLC in Westborough, Mass., Thursday Oct. 11, 2012, a separate pharmaceutical firm with common ownership of New England Compounding Center, the source of steroid shots suspected in the outbreak of rare fungal meningitis. Ameridose LLC has agreed to temporarily stop its compounding and manufacturing operations as a precaution while regulators inspect its facilities, but the measure is being taken as a precaution, not because of evidence of contamination, officials said. Ameridose was accused by a business customer this year of failing to separate sterile and non-sterile products in its warehouse, charges it vehemently denied. (AP Photo/Elise Amendola)

Two men stand guard outside the entrance to Ameridose LLC in Westborough, Mass., Thursday Oct. 11, 2012, a separate pharmaceutical firm with common ownership of New England Compounding Center, the source of steroid shots suspected in the outbreak of rare fungal meningitis. Ameridose LLC has agreed to temporarily stop its compounding and manufacturing operations as a precaution while regulators inspect its facilities, but the measure is being taken as a precaution, not because of evidence of contamination, officials said. Ameridose was accused by a business customer this year of failing to separate sterile and non-sterile products in its warehouse, charges it vehemently denied. (AP Photo/Elise Amendola)